Literature DB >> 12449739

Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma.

Shahid Ahmed1, Anita Karim Siddiqui, Kanti R Rai.   

Abstract

Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma is a distinct subgroup of non-Hodgkin's lymphoma. Chronic antigen stimulation, triggered by autoimmune process or persistent infection may precede the development of BALT lymphoma. The lymphoma cells originate from the marginal zone and by invading the bronchial epithelial tissue, give rise to the lymphoepithelial lesion. BALT lymphoma shares the morphologic, immunophenotypic, and cytogenetic characteristics of other mucosa associated lymphoid tissue lymphomas. A majority of the patients are asymptomatic and pulmonary lesions are incidentally discovered on a routine chest radiograph. However, the clinical and radiographic features of BALT lymphoma are nonspecific. The disease is often localized at the time of diagnosis and responds favorably to local treatment, but the optimal management is not clearly defined. Overall, BALT lymphoma has a favorable prognosis and is associated with long-term survival.

Entities:  

Mesh:

Year:  2002        PMID: 12449739     DOI: 10.1081/cnv-120005924

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  15 in total

1.  BALToma masquerading as pulmonary tuberculosis.

Authors:  Rahul Magazine; Hameed Aboobackar Shahul; Vidya Monappa; Bharti Chogtu
Journal:  BMJ Case Rep       Date:  2014-11-14

2.  Bronchus-associated lymphoid tissue lymphoma stage IV with subsequent histologic transformation to an aggressive lymphoma: A case report.

Authors:  Rajeev Swarup
Journal:  J Med Case Rep       Date:  2011-09-12

3.  Pulmonary mucosa-associated lymphoid tissue lymphoma: 18F-FDG PET/CT and CT findings in 28 patients.

Authors:  Domenico Albano; Andrea Borghesi; Giovanni Bosio; Mattia Bertoli; Roberto Maroldi; Raffaele Giubbini; Francesco Bertagna
Journal:  Br J Radiol       Date:  2017-10-03       Impact factor: 3.039

4.  Marginal zone B-cell lymphoma of the pulmonary mucosa-associated lymphoid tissue: A case report.

Authors:  Hong Li; Ting Wang; Xiaohong Wei; Xiaomin Dang
Journal:  Oncol Lett       Date:  2015-06-16       Impact factor: 2.967

5.  Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma.

Authors:  Ikue Okamura; Hisao Imai; Keita Mori; Kazuto Ogura; Atsushi Isoda; Keichiro Mihara; Morio Matsumoto; Ryusei Saito; Toshiaki Takahashi; Takashi Ikeda
Journal:  Int J Hematol       Date:  2014-11-07       Impact factor: 2.490

6.  Primary endobronchial marginal zone B-cell lymphoma of bronchus-associated lymphoid tissue: CT findings in 7 patients.

Authors:  Ra Gyoung Yoon; Mi Young Kim; Jae Woo Song; Eun Jin Chae; Chang Min Choi; SeJin Jang
Journal:  Korean J Radiol       Date:  2013-02-22       Impact factor: 3.500

Review 7.  [Radiological diagnostics of Hodgkin- and non-Hodgkin lymphomas of the thorax].

Authors:  M Uffmann; C Schaefer-Prokop
Journal:  Radiologe       Date:  2004-05       Impact factor: 0.635

8.  A Case of Synchronous Lung Adenocarcinoma and Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type.

Authors:  Chi Young Jung; Kun Young Kwon
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-07-31

9.  Bronchus-associated lymphoid tissue lymphoma in a patient with primary Sjögren's syndrome.

Authors:  Francesca Ingegnoli; Alba Sciascera; Valentina Galbiati; Vincenzo Corbelli; Enzo D'Ingianna; Flavio Fantini
Journal:  Rheumatol Int       Date:  2008-07-01       Impact factor: 3.580

10.  MALT Lymphomas.

Authors:  Sami N Malek; Amy J Hatfield; Ian W Flinn
Journal:  Curr Treat Options Oncol       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.